IHH Healthcare (“IHH”), a multinational healthcare provider, along with its subsidiary Fortis Healthcare, has announced the winners of the inaugural IHH Catalyst | Fortis India Edition, an initiative aimed at supporting healthcare innovation and entrepreneurship in India.
At the demo day, 10 healthcare startups presented their solutions before a jury comprising healthcare leaders, clinicians, investors, and industry experts, following a structured 12 week accelerator programme. The programme included mentorship, clinical validation, operational refinement, and opportunities for real world testing within the Fortis ecosystem.
The winners were selected based on four evaluation criteria: team, innovation, impact and scalability, and business potential. The assessment framework focused on clinical relevance, implementation readiness, and the potential to address healthcare challenges at scale.
eNext ICU was named the winner of the 2026 edition for its 24×7 Tele ICU platform, which aims to address the shortage of intensivists, particularly in Tier II and Tier III cities. RNT Health Insights was named the first runner up for developing AI powered medical devices designed to improve the early detection of upper gastrointestinal cancers during routine endoscopic procedures. Cartogene Therapeutics secured the second runner up position for its efforts to make CAR T cell therapy more accessible and affordable for patients with blood cancers in India.
Launched in February 2026 as the first regional edition of IHH Healthcare’s global incubator platform, the programme received 195 applications from healthcare startups across India. Following a multi stage evaluation process, 10 startups were selected for the inaugural cohort.
The inaugural cohort comprised Cartogene Therapeutics, CarePal Money, Tatvacare, MicroHeal, RNT Health Insights, Nalagenetics, Sunfox Technologies, eNext ICU, Kubo Care, and Cureous Labs.
